Open-Label Extension Study to Evaluate the Safety, Tolerability and Activity of Oral Fampridine-SR in Patients With Multiple Sclerosis Who Participated in the MS-F204 Trial
Clinical trial NCT00649792 · COMPLETED
Trial details
- NCT number
- NCT00649792
- Sponsor
- Acorda Therapeutics
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2007-08-01
- Primary completion
- 2011-01-01
- Enrollment
- 214
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.